Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Bicycle Therapeutics PLC (ADR) - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
BCYC
Nasdaq
8731
https://www.bicycletherapeutics.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Bicycle Therapeutics PLC (ADR)
Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
- Apr 24th, 2024 2:05 pm
Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- Apr 2nd, 2024 11:00 am
Bicycle Therapeutics to Present at the AACR Annual Meeting 2024
- Mar 5th, 2024 9:35 pm
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
- Feb 28th, 2024 12:00 pm
Earnings Update: Bicycle Therapeutics plc (NASDAQ:BCYC) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts
- Feb 23rd, 2024 11:51 am
Bicycle Therapeutics Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
- Feb 21st, 2024 7:25 pm
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
- Feb 20th, 2024 12:05 pm
Bicycle Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Feb 7th, 2024 12:00 pm
15 Small-Cap Stocks with High Potential
- Jan 22nd, 2024 3:54 pm
Bicycle Therapeutics PLC CEO Kevin Lee Sells 8,703 Shares
- Jan 5th, 2024 7:02 am
Bicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D Day
- Dec 14th, 2023 12:00 pm
Bicycle Therapeutics to Host R&D Day on December 14
- Nov 30th, 2023 12:00 pm
Bicycle Therapeutics plc (NASDAQ:BCYC) Analysts Just Trimmed Their Revenue Forecasts By 13%
- Nov 7th, 2023 10:02 am
Bicycle Therapeutics PLC (BCYC) Reports Q3 2023 Financial Results and Upcoming R&D Day
- Nov 2nd, 2023 12:46 pm
Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results and Announces Upcoming R&D Day
- Nov 2nd, 2023 11:00 am
‘The Stage Is Set for a Rally’: Canaccord Sees up to 290% Upside for These 3 Stocks
- Nov 2nd, 2023 10:04 am
Bicycle Therapeutics Selected to Participate in FDA Program to Expedite Commercial Manufacturing Readiness of BT8009 for Metastatic Bladder Cancer
- Oct 19th, 2023 11:00 am
Macomics Announces the Appointment of Kevin Lee as Independent Non-Executive Director
- Oct 19th, 2023 8:00 am
An excellent week for Bicycle Therapeutics plc's (NASDAQ:BCYC) institutional owners who own 64% as one-year returns inch higher
- Oct 7th, 2023 1:39 pm
Biotech Stock Roundup: MRNAs Pipeline News, RCKT, BCYC Rally on Study Updates
- Sep 14th, 2023 2:12 pm
Scroll